1. Home
  2. BODI vs VRCA Comparison

BODI vs VRCA Comparison

Compare BODI & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Beachbody Company Inc.

BODI

The Beachbody Company Inc.

HOLD

Current Price

$10.94

Market Cap

75.4M

Sector

Industrials

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$5.51

Market Cap

89.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BODI
VRCA
Founded
1998
2013
Country
United States
United States
Employees
270
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.4M
89.7M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BODI
VRCA
Price
$10.94
$5.51
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$15.00
$17.00
AVG Volume (30 Days)
18.2K
25.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$20.48
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
370.22
52 Week Low
$4.05
$3.28
52 Week High
$16.87
$9.82

Technical Indicators

Market Signals
Indicator
BODI
VRCA
Relative Strength Index (RSI) 56.51 48.22
Support Level $9.47 $5.32
Resistance Level $11.18 $6.29
Average True Range (ATR) 0.59 0.39
MACD -0.01 0.01
Stochastic Oscillator 80.47 60.92

Price Performance

Historical Comparison
BODI
VRCA

About BODI The Beachbody Company Inc.

The Beachbody Co Inc is a fitness and nutrition company providing fitness, nutrition, and stress-reducing programs to its customers. a results-oriented company at the intersection of wellness, technology, and media. The company developed one of the original fitness digital streaming platforms with an extensive library of content containing streaming programs and streaming videos. Company products include Digital Subscriptions, Nutritional Products, and Connected Fitness Products, where the majority of revenue is from Digital Subscriptions. The Company has one operating and reporting segment. Geographically operates in the USA and the rest of the world, with maximum revenue from the United States.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: